Skip to content

Clinical trials

Lung Diseases trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: India Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20081
20091
20162
20171
20182
20191
20201
20222
20232
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting8
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
All India Institute of Medical Sciences2
AstraZeneca2
CENTOGENE GmbH Rostock2
Eli Lilly and Company2
All India Institute of Medical Sciences, Bhubaneswar1
Eko Devices, Inc.1
Innowage Limited1
Insmed Incorporated1
Johns Hopkins University1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases18
Respiratory Tract Diseases4
Respiratory Tract Infections4
COVID-192
Infections2
Influenza, Human2
Kidney Diseases2
Lung Neoplasms2
Macroglossia2
Neoplasms2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.